Olanzapine Versus Ziprasidone: Results of a 28-Week Double-Blind Study in Patients With Schizophrenia von Breier, Alan, Berg, Paul H., Thakore, Jogin H., Naber, Dieter, Gattaz, Wagner F., Cavazzoni, Patrizia, Walker, Daniel J., Roychowdhury, Suraja M., Kane, John M.

Volltext

Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial von Cavazzoni, Patrizia, Tanaka, Yoko, Roychowdhury, Suraja M., Breier, Alan, Allison, David B.

Volltext

Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-control... von Learned, Susan, Graff, Ole, Roychowdhury, Suraja, Moate, Rachel, Krishnan, K Ranga, Archer, Graeme, Modell, Jack G, Alexander, Robert, Zamuner, Stefano, Lavergne, Agnes, Evoniuk, Gary, Ratti, Emiliangelo

Volltext

Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia von Kinon, Bruce J, Roychowdhury, Suraja M, Milton, Denai R, Hill, Angela L

Volltext